alfibrate and pirozadil

alfibrate has been researched along with pirozadil* in 3 studies

Trials

2 trial(s) available for alfibrate and pirozadil

ArticleYear
[Clinical trial of a new drug for the treatment of atherosclerosis: pirozadil (722-D) (author's transl)].
    Medicina clinica, 1982, May-16, Volume: 78, Issue:10

    Topics: Clinical Trials as Topic; Clofibric Acid; Coronary Disease; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Pyridines; Random Allocation

1982
[A double blind study of the new hypolipidemic agent pirozadil (722-D) using patients with ischemic heart disease (author's transl)].
    Medicina clinica, 1982, May-01, Volume: 78, Issue:9

    Topics: Aged; Clinical Trials as Topic; Clofibric Acid; Coronary Disease; Double-Blind Method; Female; Humans; Hypolipidemic Agents; Male; Middle Aged; Pyridines; Random Allocation

1982

Other Studies

1 other study(ies) available for alfibrate and pirozadil

ArticleYear
[Single-blind study of the efficacy of pirozadil versus alufibrate in the treatment of primary hyperlipoproteinemias].
    Revista de medicina de la Universidad de Navarra, 1982, Volume: 26, Issue:1

    Pirozadil and alufibrate are compared by a single-blind study over two groups 20 patients with primary hyperlipoproteinemia. Pirozadil seems more effective as a cholesterol-lowering agent. There were no adverse reactions. We conclude that pirozadil can be a valuable agent in preventing atherosclerotic disease.

    Topics: Cholesterol; Clofibrate; Clofibric Acid; Drug Evaluation; Female; Humans; Hyperlipoproteinemias; Lipoproteins; Male; Middle Aged; Platelet Aggregation; Pyridines; Random Allocation

1982